OSTN (115-133) [6048]



OSTN (115-133)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCN=C(N)N)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O
InChIKey LBPSGCKOVGOHBM-ZGLUUWDISA-N
Sequence RFGIPMDRIGRNRLSNSRG
HELM PEPTIDE1{R.F.G.I.P.M.D.R.I.G.R.N.R.L.S.N.S.R.G}$$$$

Chemical Properties

Hydrogen bond acceptors 31
Hydrogen bond donors 34
Rotatable bonds 75
Log P -14.863
Molecular weight (Da) 2201.2
Stereochemistry info partial

Database connections



Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

OSTN (115-133)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.